Industry Research Reports

Home > Reports > Chemical & Material > Global Pharmaceutical Pregelatinized Starch Market Research Report 2026

Global Pharmaceutical Pregelatinized Starch Market Research Report 2026

Industry: Chemical & Material

Published Date: 2026-04-18

Pages: 136 Pages

Report ld: 6500543

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Pharmaceutical Pregelatinized Starch Market Size(US$)

CAGR 2026-2032

4.4%

Market Size,2032

USD 2,590

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 2,000 million

Market Forecast in 2032(Value)

US$ 2,590 million

CAGR

4.4%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Pharmaceutical Pregelatinized Starch market was valued at US$ 1924 million in 2025 and is anticipated to reach US$ 2590 million by 2032, at a CAGR of 4.4% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Pregelatinized Starch competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Pharmaceutical Pregelatinized Starch market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Pregelatinized Starch. The Pharmaceutical Pregelatinized Starch market size, estimates, and forecasts are provided in terms of output/shipments (K Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pharmaceutical Pregelatinized Starch market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pharmaceutical Pregelatinized Starch manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Signet
MIKEM
Nippon Starch Chemical Co.,Ltd.
Patel Chem Specialties Pvt Ltd
Roquette
SMS
Starch Asia
Universal Starch Chem Allied Ltd.
Cargill
Tate&Lyle
Visco Starch
Galam
Banpong Tapioca Flour Industrial
Crest Cellulose
DFE Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Fully Pregelatinized Starch
Partially Pregelatinized Starch

Segment by Application

Capsule
Tablet

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for Pharmaceutical Pregelatinized Starch manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.

Chapter 3: Examines Pharmaceutical Pregelatinized Starch production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.

Chapter 4: Analyzes Pharmaceutical Pregelatinized Starch consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.

Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.

Chapter 8: Reviews the industry value chain, including upstream and downstream segments.

Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 10: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Pharmaceutical Pregelatinized Starch Market Overview

1.1 Product Definition

1.2 Pharmaceutical Pregelatinized Starch by Type

1.2.1 Global Pharmaceutical Pregelatinized Starch Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Fully Pregelatinized Starch

1.2.3 Partially Pregelatinized Starch

1.3 Pharmaceutical Pregelatinized Starch by Application

1.3.1 Global Pharmaceutical Pregelatinized Starch Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Capsule

1.3.3 Tablet

1.4 Global Market Growth Prospects

1.4.1 Global Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Pharmaceutical Pregelatinized Starch Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Pharmaceutical Pregelatinized Starch Production Estimates and Forecasts (2021–2032)

1.4.4 Global Pharmaceutical Pregelatinized Starch Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Pharmaceutical Pregelatinized Starch Production Market Share by Manufacturers (2021–2026)

2.2 Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Pharmaceutical Pregelatinized Starch, Industry Ranking, 2024 vs 2025

2.4 Global Pharmaceutical Pregelatinized Starch Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Pharmaceutical Pregelatinized Starch Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Product Offerings and Applications

2.8 Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Date of Entry into the Industry

2.9 Pharmaceutical Pregelatinized Starch Market Competitive Situation and Trends

2.9.1 Pharmaceutical Pregelatinized Starch Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Pharmaceutical Pregelatinized Starch Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Pharmaceutical Pregelatinized Starch Production by Region

3.1 Global Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Pharmaceutical Pregelatinized Starch Production Value by Region (2021–2032)

3.2.1 Global Pharmaceutical Pregelatinized Starch Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Pharmaceutical Pregelatinized Starch by Region (2027–2032)

3.3 Global Pharmaceutical Pregelatinized Starch Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Pharmaceutical Pregelatinized Starch Production Volume by Region (2021–2032)

3.4.1 Global Pharmaceutical Pregelatinized Starch Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Pharmaceutical Pregelatinized Starch by Region (2027–2032)

3.5 Global Pharmaceutical Pregelatinized Starch Market Price Analysis by Region (2021–2032)

3.6 Global Pharmaceutical Pregelatinized Starch Production, Value, and Year-over-Year Growth

3.6.1 North America Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan Pharmaceutical Pregelatinized Starch Production Value Estimates and Forecasts (2021–2032)

4 Pharmaceutical Pregelatinized Starch Consumption by Region

4.1 Global Pharmaceutical Pregelatinized Starch Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Pharmaceutical Pregelatinized Starch Consumption by Region (2021–2032)

4.2.1 Global Pharmaceutical Pregelatinized Starch Consumption by Region (2021–2026)

4.2.2 Global Pharmaceutical Pregelatinized Starch Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Pharmaceutical Pregelatinized Starch Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Pharmaceutical Pregelatinized Starch Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Pharmaceutical Pregelatinized Starch Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Pharmaceutical Pregelatinized Starch Production by Type (2021–2032)

5.1.1 Global Pharmaceutical Pregelatinized Starch Production by Type (2021–2026)

5.1.2 Global Pharmaceutical Pregelatinized Starch Production by Type (2027–2032)

5.1.3 Global Pharmaceutical Pregelatinized Starch Production Market Share by Type (2021–2032)

5.2 Global Pharmaceutical Pregelatinized Starch Production Value by Type (2021–2032)

5.2.1 Global Pharmaceutical Pregelatinized Starch Production Value by Type (2021–2026)

5.2.2 Global Pharmaceutical Pregelatinized Starch Production Value by Type (2027–2032)

5.2.3 Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Type (2021–2032)

5.3 Global Pharmaceutical Pregelatinized Starch Price by Type (2021–2032)

6 Segment by Application

6.1 Global Pharmaceutical Pregelatinized Starch Production by Application (2021–2032)

6.1.1 Global Pharmaceutical Pregelatinized Starch Production by Application (2021–2026)

6.1.2 Global Pharmaceutical Pregelatinized Starch Production by Application (2027–2032)

6.1.3 Global Pharmaceutical Pregelatinized Starch Production Market Share by Application (2021–2032)

6.2 Global Pharmaceutical Pregelatinized Starch Production Value by Application (2021–2032)

6.2.1 Global Pharmaceutical Pregelatinized Starch Production Value by Application (2021–2026)

6.2.2 Global Pharmaceutical Pregelatinized Starch Production Value by Application (2027–2032)

6.2.3 Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Application (2021–2032)

6.3 Global Pharmaceutical Pregelatinized Starch Price by Application (2021–2032)

7 Key Companies Profiled

7.1 Signet

7.1.1 Signet Pharmaceutical Pregelatinized Starch Company Information

7.1.2 Signet Pharmaceutical Pregelatinized Starch Product Portfolio

7.1.3 Signet Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 Signet Main Business and Markets Served

7.1.5 Signet Recent Developments/Updates

7.2 MIKEM

7.2.1 MIKEM Pharmaceutical Pregelatinized Starch Company Information

7.2.2 MIKEM Pharmaceutical Pregelatinized Starch Product Portfolio

7.2.3 MIKEM Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 MIKEM Main Business and Markets Served

7.2.5 MIKEM Recent Developments/Updates

7.3 Nippon Starch Chemical Co.,Ltd.

7.3.1 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Company Information

7.3.2 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Product Portfolio

7.3.3 Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 Nippon Starch Chemical Co.,Ltd. Main Business and Markets Served

7.3.5 Nippon Starch Chemical Co.,Ltd. Recent Developments/Updates

7.4 Patel Chem Specialties Pvt Ltd

7.4.1 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Company Information

7.4.2 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Product Portfolio

7.4.3 Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Patel Chem Specialties Pvt Ltd Main Business and Markets Served

7.4.5 Patel Chem Specialties Pvt Ltd Recent Developments/Updates

7.5 Roquette

7.5.1 Roquette Pharmaceutical Pregelatinized Starch Company Information

7.5.2 Roquette Pharmaceutical Pregelatinized Starch Product Portfolio

7.5.3 Roquette Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 Roquette Main Business and Markets Served

7.5.5 Roquette Recent Developments/Updates

7.6 SMS

7.6.1 SMS Pharmaceutical Pregelatinized Starch Company Information

7.6.2 SMS Pharmaceutical Pregelatinized Starch Product Portfolio

7.6.3 SMS Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 SMS Main Business and Markets Served

7.6.5 SMS Recent Developments/Updates

7.7 Starch Asia

7.7.1 Starch Asia Pharmaceutical Pregelatinized Starch Company Information

7.7.2 Starch Asia Pharmaceutical Pregelatinized Starch Product Portfolio

7.7.3 Starch Asia Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 Starch Asia Main Business and Markets Served

7.7.5 Starch Asia Recent Developments/Updates

7.8 Universal Starch Chem Allied Ltd.

7.8.1 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Company Information

7.8.2 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Product Portfolio

7.8.3 Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 Universal Starch Chem Allied Ltd. Main Business and Markets Served

7.8.5 Universal Starch Chem Allied Ltd. Recent Developments/Updates

7.9 Cargill

7.9.1 Cargill Pharmaceutical Pregelatinized Starch Company Information

7.9.2 Cargill Pharmaceutical Pregelatinized Starch Product Portfolio

7.9.3 Cargill Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.9.4 Cargill Main Business and Markets Served

7.9.5 Cargill Recent Developments/Updates

7.10 Tate&Lyle

7.10.1 Tate&Lyle Pharmaceutical Pregelatinized Starch Company Information

7.10.2 Tate&Lyle Pharmaceutical Pregelatinized Starch Product Portfolio

7.10.3 Tate&Lyle Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.10.4 Tate&Lyle Main Business and Markets Served

7.10.5 Tate&Lyle Recent Developments/Updates

7.11 Visco Starch

7.11.1 Visco Starch Pharmaceutical Pregelatinized Starch Company Information

7.11.2 Visco Starch Pharmaceutical Pregelatinized Starch Product Portfolio

7.11.3 Visco Starch Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.11.4 Visco Starch Main Business and Markets Served

7.11.5 Visco Starch Recent Developments/Updates

7.12 Galam

7.12.1 Galam Pharmaceutical Pregelatinized Starch Company Information

7.12.2 Galam Pharmaceutical Pregelatinized Starch Product Portfolio

7.12.3 Galam Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.12.4 Galam Main Business and Markets Served

7.12.5 Galam Recent Developments/Updates

7.13 Banpong Tapioca Flour Industrial

7.13.1 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Company Information

7.13.2 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Product Portfolio

7.13.3 Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.13.4 Banpong Tapioca Flour Industrial Main Business and Markets Served

7.13.5 Banpong Tapioca Flour Industrial Recent Developments/Updates

7.14 Crest Cellulose

7.14.1 Crest Cellulose Pharmaceutical Pregelatinized Starch Company Information

7.14.2 Crest Cellulose Pharmaceutical Pregelatinized Starch Product Portfolio

7.14.3 Crest Cellulose Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.14.4 Crest Cellulose Main Business and Markets Served

7.14.5 Crest Cellulose Recent Developments/Updates

7.15 DFE Pharma

7.15.1 DFE Pharma Pharmaceutical Pregelatinized Starch Company Information

7.15.2 DFE Pharma Pharmaceutical Pregelatinized Starch Product Portfolio

7.15.3 DFE Pharma Pharmaceutical Pregelatinized Starch Production, Value, Price, and Gross Margin (2021–2026)

7.15.4 DFE Pharma Main Business and Markets Served

7.15.5 DFE Pharma Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Pharmaceutical Pregelatinized Starch Industry Chain Analysis

8.2 Pharmaceutical Pregelatinized Starch Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Pharmaceutical Pregelatinized Starch Production Modes and Processes

8.4 Pharmaceutical Pregelatinized Starch Sales and Marketing

8.4.1 Pharmaceutical Pregelatinized Starch Sales Channels

8.4.2 Pharmaceutical Pregelatinized Starch Distributors

8.5 Pharmaceutical Pregelatinized Starch Customer Analysis

9 Pharmaceutical Pregelatinized Starch Market Dynamics

9.1 Pharmaceutical Pregelatinized Starch Industry Trends

9.2 Pharmaceutical Pregelatinized Starch Market Drivers

9.3 Pharmaceutical Pregelatinized Starch Market Challenges

9.4 Pharmaceutical Pregelatinized Starch Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Pharmaceutical Pregelatinized Starch Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Pharmaceutical Pregelatinized Starch Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Pharmaceutical Pregelatinized Starch Production Capacity (K Tons) by Manufacturers in 2025

Table 4. Global Pharmaceutical Pregelatinized Starch Production by Manufacturers (K Tons), 2021–2026

Table 5. Global Pharmaceutical Pregelatinized Starch Production Market Share by Manufacturers (2021–2026)

Table 6. Global Pharmaceutical Pregelatinized Starch Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Pharmaceutical Pregelatinized Starch Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Pharmaceutical Pregelatinized Starch, Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical Pregelatinized Starch Production Value, 2025

Table 10. Global Market Pharmaceutical Pregelatinized Starch Average Price by Manufacturers (US$/Ton), 2021–2026

Table 11. Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Product Offerings and Applications

Table 13. Global Key Manufacturers of Pharmaceutical Pregelatinized Starch, Date of Entry into the Industry

Table 14. Global Pharmaceutical Pregelatinized Starch Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Pharmaceutical Pregelatinized Starch Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Region (2021–2026)

Table 19. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Pharmaceutical Pregelatinized Starch Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Pharmaceutical Pregelatinized Starch Production Comparison by Region: 2021 vs 2025 vs 2032 (K Tons)

Table 22. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Region (2021–2026)

Table 23. Global Pharmaceutical Pregelatinized Starch Production Market Share by Region (2021–2026)

Table 24. Global Pharmaceutical Pregelatinized Starch Production (K Tons) Forecast by Region (2027–2032)

Table 25. Global Pharmaceutical Pregelatinized Starch Production Market Share Forecast by Region (2027–2032)

Table 26. Global Pharmaceutical Pregelatinized Starch Market Average Price (US$/Ton) by Region (2021–2026)

Table 27. Global Pharmaceutical Pregelatinized Starch Market Average Price (US$/Ton) by Region (2027–2032)

Table 28. Global Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Tons)

Table 29. Global Pharmaceutical Pregelatinized Starch Consumption by Region (K Tons), 2021–2026

Table 30. Global Pharmaceutical Pregelatinized Starch Consumption Market Share by Region (2021–2026)

Table 31. Global Pharmaceutical Pregelatinized Starch Forecasted Consumption by Region (K Tons), 2027–2032

Table 32. Global Pharmaceutical Pregelatinized Starch Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Tons)

Table 34. North America Pharmaceutical Pregelatinized Starch Consumption by Country (K Tons), 2021–2026

Table 35. North America Pharmaceutical Pregelatinized Starch Consumption by Country (K Tons), 2027–2032

Table 36. Europe Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Tons)

Table 37. Europe Pharmaceutical Pregelatinized Starch Consumption by Country (K Tons), 2021–2026

Table 38. Europe Pharmaceutical Pregelatinized Starch Consumption by Country (K Tons), 2027–2032

Table 39. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Tons)

Table 40. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption by Region (K Tons), 2021–2026

Table 41. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption by Region (K Tons), 2027–2032

Table 42. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Tons)

Table 43. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption by Country (K Tons), 2021–2026

Table 44. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption by Country (K Tons), 2027–2032

Table 45. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Type (2021–2026)

Table 46. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Type (2027–2032)

Table 47. Global Pharmaceutical Pregelatinized Starch Production Market Share by Type (2021–2026)

Table 48. Global Pharmaceutical Pregelatinized Starch Production Market Share by Type (2027–2032)

Table 49. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Type (2021–2026)

Table 52. Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Type (2027–2032)

Table 53. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Type (2021–2026)

Table 54. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Type (2027–2032)

Table 55. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Application (2021–2026)

Table 56. Global Pharmaceutical Pregelatinized Starch Production (K Tons) by Application (2027–2032)

Table 57. Global Pharmaceutical Pregelatinized Starch Production Market Share by Application (2021–2026)

Table 58. Global Pharmaceutical Pregelatinized Starch Production Market Share by Application (2027–2032)

Table 59. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Application (2021–2026)

Table 62. Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Application (2027–2032)

Table 63. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Application (2021–2026)

Table 64. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Application (2027–2032)

Table 65. Signet Pharmaceutical Pregelatinized Starch Company Information

Table 66. Signet Pharmaceutical Pregelatinized Starch Specification and Application

Table 67. Signet Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 68. Signet Main Business and Markets Served

Table 69. Signet Recent Developments/Updates

Table 70. MIKEM Pharmaceutical Pregelatinized Starch Company Information

Table 71. MIKEM Pharmaceutical Pregelatinized Starch Specification and Application

Table 72. MIKEM Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 73. MIKEM Main Business and Markets Served

Table 74. MIKEM Recent Developments/Updates

Table 75. Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Company Information

Table 76. Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Specification and Application

Table 77. Nippon Starch Chemical Co.,Ltd. Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 78. Nippon Starch Chemical Co.,Ltd. Main Business and Markets Served

Table 79. Nippon Starch Chemical Co.,Ltd. Recent Developments/Updates

Table 80. Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Company Information

Table 81. Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Specification and Application

Table 82. Patel Chem Specialties Pvt Ltd Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 83. Patel Chem Specialties Pvt Ltd Main Business and Markets Served

Table 84. Patel Chem Specialties Pvt Ltd Recent Developments/Updates

Table 85. Roquette Pharmaceutical Pregelatinized Starch Company Information

Table 86. Roquette Pharmaceutical Pregelatinized Starch Specification and Application

Table 87. Roquette Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 88. Roquette Main Business and Markets Served

Table 89. Roquette Recent Developments/Updates

Table 90. SMS Pharmaceutical Pregelatinized Starch Company Information

Table 91. SMS Pharmaceutical Pregelatinized Starch Specification and Application

Table 92. SMS Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 93. SMS Main Business and Markets Served

Table 94. SMS Recent Developments/Updates

Table 95. Starch Asia Pharmaceutical Pregelatinized Starch Company Information

Table 96. Starch Asia Pharmaceutical Pregelatinized Starch Specification and Application

Table 97. Starch Asia Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 98. Starch Asia Main Business and Markets Served

Table 99. Starch Asia Recent Developments/Updates

Table 100. Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Company Information

Table 101. Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Specification and Application

Table 102. Universal Starch Chem Allied Ltd. Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 103. Universal Starch Chem Allied Ltd. Main Business and Markets Served

Table 104. Universal Starch Chem Allied Ltd. Recent Developments/Updates

Table 105. Cargill Pharmaceutical Pregelatinized Starch Company Information

Table 106. Cargill Pharmaceutical Pregelatinized Starch Specification and Application

Table 107. Cargill Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 108. Cargill Main Business and Markets Served

Table 109. Cargill Recent Developments/Updates

Table 110. Tate&Lyle Pharmaceutical Pregelatinized Starch Company Information

Table 111. Tate&Lyle Pharmaceutical Pregelatinized Starch Specification and Application

Table 112. Tate&Lyle Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 113. Tate&Lyle Main Business and Markets Served

Table 114. Tate&Lyle Recent Developments/Updates

Table 115. Visco Starch Pharmaceutical Pregelatinized Starch Company Information

Table 116. Visco Starch Pharmaceutical Pregelatinized Starch Specification and Application

Table 117. Visco Starch Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 118. Visco Starch Main Business and Markets Served

Table 119. Visco Starch Recent Developments/Updates

Table 120. Galam Pharmaceutical Pregelatinized Starch Company Information

Table 121. Galam Pharmaceutical Pregelatinized Starch Specification and Application

Table 122. Galam Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 123. Galam Main Business and Markets Served

Table 124. Galam Recent Developments/Updates

Table 125. Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Company Information

Table 126. Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Specification and Application

Table 127. Banpong Tapioca Flour Industrial Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 128. Banpong Tapioca Flour Industrial Main Business and Markets Served

Table 129. Banpong Tapioca Flour Industrial Recent Developments/Updates

Table 130. Crest Cellulose Pharmaceutical Pregelatinized Starch Company Information

Table 131. Crest Cellulose Pharmaceutical Pregelatinized Starch Specification and Application

Table 132. Crest Cellulose Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 133. Crest Cellulose Main Business and Markets Served

Table 134. Crest Cellulose Recent Developments/Updates

Table 135. DFE Pharma Pharmaceutical Pregelatinized Starch Company Information

Table 136. DFE Pharma Pharmaceutical Pregelatinized Starch Specification and Application

Table 137. DFE Pharma Pharmaceutical Pregelatinized Starch Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 138. DFE Pharma Main Business and Markets Served

Table 139. DFE Pharma Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Pharmaceutical Pregelatinized Starch Distributors List

Table 143. Pharmaceutical Pregelatinized Starch Customers List

Table 144. Pharmaceutical Pregelatinized Starch Market Trends

Table 145. Pharmaceutical Pregelatinized Starch Market Drivers

Table 146. Pharmaceutical Pregelatinized Starch Market Challenges

Table 147. Pharmaceutical Pregelatinized Starch Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pharmaceutical Pregelatinized Starch

Figure 2. Global Pharmaceutical Pregelatinized Starch Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Pharmaceutical Pregelatinized Starch Market Share by Type: 2025 vs 2032

Figure 4. Fully Pregelatinized Starch Product Picture

Figure 5. Partially Pregelatinized Starch Product Picture

Figure 6. Global Pharmaceutical Pregelatinized Starch Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Pharmaceutical Pregelatinized Starch Market Share by Application: 2025 vs 2032

Figure 8. Capsule

Figure 9. Tablet

Figure 10. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Pharmaceutical Pregelatinized Starch Production Value (US$ Million), 2021–2032

Figure 12. Global Pharmaceutical Pregelatinized Starch Production Capacity (K Tons), 2021–2032

Figure 13. Global Pharmaceutical Pregelatinized Starch Production (K Tons), 2021–2032

Figure 14. Global Pharmaceutical Pregelatinized Starch Average Price (US$/Ton), 2021–2032

Figure 15. Pharmaceutical Pregelatinized Starch Report Years Considered

Figure 16. Pharmaceutical Pregelatinized Starch Production Share by Manufacturers in 2025

Figure 17. Global Pharmaceutical Pregelatinized Starch Production Value Share by Manufacturers (2025)

Figure 18. Pharmaceutical Pregelatinized Starch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Top 5 and Top 10 Global Players: Market Share by Pharmaceutical Pregelatinized Starch Revenue in 2025

Figure 20. Global Pharmaceutical Pregelatinized Starch Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 21. Global Pharmaceutical Pregelatinized Starch Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 22. Global Pharmaceutical Pregelatinized Starch Production Comparison by Region: 2021 vs 2025 vs 2032 (K Tons)

Figure 23. Global Pharmaceutical Pregelatinized Starch Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 24. North America Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Growth Rate (2021–2032)

Figure 25. Europe Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Growth Rate (2021–2032)

Figure 26. China Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Growth Rate (2021–2032)

Figure 27. Japan Pharmaceutical Pregelatinized Starch Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. Global Pharmaceutical Pregelatinized Starch Consumption by Region: 2021 vs 2025 vs 2032 (K Tons)

Figure 29. Global Pharmaceutical Pregelatinized Starch Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 30. North America Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 31. North America Pharmaceutical Pregelatinized Starch Consumption Market Share by Country (2021–2032)

Figure 32. U.S. Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 33. Canada Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 34. Europe Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 35. Europe Pharmaceutical Pregelatinized Starch Consumption Market Share by Country (2021–2032)

Figure 36. Germany Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 37. France Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 38. U.K. Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 39. Italy Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 40. Russia Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 41. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 42. Asia Pacific Pharmaceutical Pregelatinized Starch Consumption Market Share by Region (2021–2032)

Figure 43. China Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 44. Japan Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 45. South Korea Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 46. China Taiwan Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 47. Southeast Asia Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 48. India Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 49. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 50. Latin America, Middle East & Africa Pharmaceutical Pregelatinized Starch Consumption Market Share by Country (2021–2032)

Figure 51. Mexico Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 52. Brazil Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 53. Turkey Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 54. GCC Countries Pharmaceutical Pregelatinized Starch Consumption and Growth Rate (K Tons), 2021–2032

Figure 55. Global Production Market Share of Pharmaceutical Pregelatinized Starch by Type (2021–2032)

Figure 56. Global Production Value Market Share of Pharmaceutical Pregelatinized Starch by Type (2021–2032)

Figure 57. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Type (2021–2032)

Figure 58. Global Production Market Share of Pharmaceutical Pregelatinized Starch by Application (2021–2032)

Figure 59. Global Production Value Market Share of Pharmaceutical Pregelatinized Starch by Application (2021–2032)

Figure 60. Global Pharmaceutical Pregelatinized Starch Price (US$/Ton) by Application (2021–2032)

Figure 61. Pharmaceutical Pregelatinized Starch Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Pharmaceutical Pregelatinized Starch in 2026? zhanKai

The global market size of Pharmaceutical Pregelatinized Starch in 2026 was 2000 Million USD.

Which companies rank high in the global Pharmaceutical Pregelatinized Starch market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Pharmaceutical Pregelatinized Starch in 2032? shouQi

What is the annual compound growth rate of the global Pharmaceutical Pregelatinized Starch market size from 2026 to 2032? shouQi

Related Reports

Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1924 million in 2025 and is projected to reach US$ 2590 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Pregelatinized Starch market size was US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 95
USD 4250.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Pregelatinized Starch market is projected to grow from US$ 1850 million in 2024 to US$ 2491 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 152
USD 4900.00
(Single User License)
Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 117
USD 3950.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2025
The global market for Pharmaceutical Pregelatinized Starch was valued at US$ 1850 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published Date: 2025-01-16
Pages: 104
USD 2900.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Insights, Forecast to 2030
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published Date: 2024-04-12
Pages: 113
USD 4900.00
(Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2024
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published Date: 2024-01-17
Pages: 119
USD 2900.00
(Single User License)

Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1924 million in 2025 and is projected to reach US$ 2590 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-06-16
Pages: 139
USD 3950.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Pregelatinized Starch market size was US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 95
USD 4250.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Pregelatinized Starch market is projected to grow from US$ 1850 million in 2024 to US$ 2491 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 152
USD 4900.00 (Single User License)
Pharmaceutical Pregelatinized Starch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Pregelatinized Starch was estimated to be worth US$ 1850 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 117
USD 3950.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2025
The global market for Pharmaceutical Pregelatinized Starch was valued at US$ 1850 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published: 2025-01-16
Pages: 104
USD 2900.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Insights, Forecast to 2030
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published: 2024-04-12
Pages: 113
USD 4900.00 (Single User License)
Global Pharmaceutical Pregelatinized Starch Market Research Report 2024
Pregelatinized starch is modified starch, which is obtained by partially or completely breaking starch granules by chemical or mechanical methods. It is often used as a binder, diluent and disintegrant in tablets. Pregelatinized starch has self-lubricating effect. When used in combination with other excipients, magnesium stearate should be added as a lubricant. This product is non-toxic and non-irritating, but it is harmful if taken in large quantities.
Published: 2024-01-17
Pages: 119
USD 2900.00 (Single User License)